Loading company…
Riskpilot
← Back to search
Sign in
Get full access
Neurosleep Consulting&Tech Lund AB
AB
Active
Org 5594285602
Spårsnögatan 46
Medical specialists activities · NACE 8622
Est. 2023
0 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2026
SEK 232K
+17% vs 2025
EBITDA margin
90.9%
+29% vs 2025
Equity ratio
81.6%
Financial strength
Net profit 2026
SEK 167K
+29% vs 2025
EBITDA — year on year
SEK millions
0M
-0M
-1M
-1M
-1M
0M
2024
0M
0%
2025
0M
0%
2026
Key figures
Annual report 2026
Revenue
SEK 232K
+17%
EBITDA
SEK 211K
+29%
Net profit
SEK 167K
+29%
Total assets
SEK 236K
+25%
Equity
SEK 192K
+24%
Employees
0
—
Company information
Legal name
Neurosleep Consulting&Tech Lund AB
Org number
5594285602
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
31 mars 2023
Share capital
SEK 25 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2026-02-28
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Konsultverksamthet och försäljning av läkartjänster inom neurologi och sömn.
Contact
Address
Spårsnögatan 46
Email
nahimiadjmal@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Medical specialists activities
Companies in Lund
All Sweden companies
Revenue
SEK millions
0M
0M
1M
1M
1M
0M
2024
0M
2025
0M
2026
EBITDA
SEK millions
0M
0M
1M
1M
1M
0M
2024
0M
2025
0M
2026
Income statement
SEK thousands
Item
2024
2025
2026
Revenue
19
199
232
Staff expenses
−0
−0
−4
EBITDA
15
163
211
Depreciation & amort.
−14
—
—
EBIT
1
163
211
Net financials
—
—
—
Profit before tax
1
163
211
Tax
−0
−34
−43
Net profit
1
130
167
Balance sheet
SEK thousands
Item
2024
2025
2026
Total assets
28
188
236
Equity
26
155
192
Long-term debt
—
—
—
Short-term debt
2
34
43
Total debt
2
34
43
Financial ratios
5-year trend
EBITDA margin
90.9%
This company
15.8%
Market median
+475% vs market
2024
2026
Equity ratio
81.6%
This company
38.2%
Market median
+114% vs market
2024
2026
Return on equity
87.0%
This company
18.4%
Market median
+373% vs market
2024
2026
Net profit margin
72.2%
This company
8.1%
Market median
+791% vs market
2024
2026
Asset turnover
0.98×
This company
1.12×
Market median
+13% vs market
2024
2026
Debt / equity
0.23×
This company
0.62×
Market median
+63% vs market
2024
2026
Annual reports & filings
Annual report 2026
Filed via Bolagsverket / SCB · Period 2025-03-01 – 2026-02-28
View
PDF
Annual report 2025
Filed via Bolagsverket / SCB · Period 2024-03-01 – 2025-02-28
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2023-03-31 – 2024-02-29
View
PDF
Management
Actively employed in the business
No data on file.
Board of directors
Non-executive oversight
Name
Role
Member since
Current (2)
AN
Adjmal Nahimi
Board of Directors
2023
CM
Corrie Mccrea Nahimi
Deputy Board Member
2023
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of Neurosleep Consulting&Tech Lund AB also hold positions in
0
other companies.
Person
Role here
Other companies
Adjmal Nahimi
Board of Directors
0 companies
Corrie Mccrea Nahimi
Deputy Board Member
0 companies